pfizer semaglutide struggles to catch up to Ozempic, Wegovy with weight-loss pill FDA declares end to Wegovy

One of our licensed medical practitioners will review the results with you to determine if Semaglutide treatment is right for you

Until then, Ryder suspects this telehealth boom will continue unabated

Time-to-Event Analysis The Kaplan-Meier survival analysis with log-rank test revealed no significant differences in terms of recurrence (p = 0.7), metastasis (p = 0.2), and death (p = 0.5) among patients undergoing GTR alone, GTR with radiation therapy, STR alone, or STR with radiation therapy

Diabetes Ther 16 , 813849 (2025)

The ongoing trial, which involves around 100 overweight or obese people, was designed to test the safety and tolerability of the drug at different doses, as well as its impact on weight and blood sugar